Published in J Virol on June 24, 2009
Innate and adaptive anti-HIV immune responses in the female reproductive tract. J Reprod Immunol (2013) 1.09
The Neonatal Fc receptor (FcRn) enhances human immunodeficiency virus type 1 (HIV-1) transcytosis across epithelial cells. PLoS Pathog (2013) 1.07
Differential transmission of HIV traversing fetal oral/intestinal epithelia and adult oral epithelia. J Virol (2011) 0.99
Caveats associated with the use of human cervical tissue for HIV and microbicide research. AIDS (2010) 0.95
The mouth: a gateway or a trap for HIV? AIDS (2010) 0.93
Interactions between HIV-1 and mucosal cells in the female reproductive tract. Am J Reprod Immunol (2014) 0.83
The calcium-induced conformation and glycosylation of scavenger-rich cysteine repeat (SRCR) domains of glycoprotein 340 influence the high affinity interaction with antigen I/II homologs. J Biol Chem (2014) 0.80
Porphyromonas gingivalis-mediated Epithelial Cell Entry of HIV-1. J Dent Res (2014) 0.78
The role of dendritic cells in driving genital tract inflammation and HIV transmission risk: are there opportunities to intervene? Innate Immun (2013) 0.77
Chlamydia trachomatis Infection of Endocervical Epithelial Cells Enhances Early HIV Transmission Events. PLoS One (2016) 0.76
An electrochemiluminescence assay for gp340 (DMBT1). Anal Biochem (2013) 0.75
Periluminal Distribution of HIV-Binding Target Cells and Gp340 in the Oral, Cervical and Sigmoid/Rectal Mucosae: A Mapping Study. PLoS One (2015) 0.75
Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med (2000) 41.18
DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell (2000) 14.43
Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet (2001) 13.32
Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem (1999) 11.87
Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. J Virol (2000) 4.87
Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. J Virol (2005) 4.61
Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5. Science (2004) 3.95
Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIV(SF162P3). J Virol (2001) 3.20
Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia. J Virol (1994) 3.05
Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier. Nat Med (1997) 2.67
Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques. J Virol (2002) 2.46
Target cells in vaginal HIV transmission. Microbes Infect (2003) 2.36
Human immunodeficiency virus type 1-specific immunity after genetic immunization is enhanced by modification of Gag and Pol expression. J Virol (2001) 2.12
Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor. Proc Natl Acad Sci U S A (1993) 1.96
Salivary agglutinin, which binds Streptococcus mutans and Helicobacter pylori, is the lung scavenger receptor cysteine-rich protein gp-340. J Biol Chem (2000) 1.89
HIV and sexually transmitted diseases: lethal synergy. Top HIV Med (2004) 1.84
Cell-free human immunodeficiency virus type 1 transcytosis through primary genital epithelial cells. J Virol (2006) 1.74
Cloning of gp-340, a putative opsonin receptor for lung surfactant protein D. Proc Natl Acad Sci U S A (1999) 1.69
Heparan sulfate targets the HIV-1 envelope glycoprotein gp120 coreceptor binding site. J Biol Chem (2005) 1.38
Identification of the bacteria-binding peptide domain on salivary agglutinin (gp-340/DMBT1), a member of the scavenger receptor cysteine-rich superfamily. J Biol Chem (2002) 1.37
DMBT1 encodes a protein involved in the immune defense and in epithelial differentiation and is highly unstable in cancer. Cancer Res (2000) 1.32
Human genital epithelial cells capture cell-free human immunodeficiency virus type 1 and transmit the virus to CD4+ Cells: implications for mechanisms of sexual transmission. J Infect Dis (2003) 1.29
HIV-1 gp41 envelope residues 650-685 exposed on native virus act as a lectin to bind epithelial cell galactosyl ceramide. J Biol Chem (2002) 1.28
DC-SIGN interactions with human immunodeficiency virus: virus binding and transfer are dissociable functions. J Virol (2001) 1.27
gp340 expressed on human genital epithelia binds HIV-1 envelope protein and facilitates viral transmission. J Immunol (2007) 1.25
A highly conserved arginine in gp120 governs HIV-1 binding to both syndecans and CCR5 via sulfated motifs. J Biol Chem (2005) 1.23
Lung and salivary scavenger receptor glycoprotein-340 contribute to the host defense against influenza A viruses. Am J Physiol Lung Cell Mol Physiol (2003) 1.23
Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion. J Virol (2004) 1.23
Hensin remodels the apical cytoskeleton and induces columnarization of intercalated epithelial cells: processes that resemble terminal differentiation. J Cell Biol (1999) 1.18
R5- and X4-HIV-1 use differentially the endometrial epithelial cells HEC-1A to ensure their own spread: implication for mechanisms of sexual transmission. Virology (2006) 1.16
Salivary agglutinin/glycoprotein-340/DMBT1: a single molecule with variable composition and with different functions in infection, inflammation and cancer. Biol Chem (2007) 1.12
DMBT1, a regulator of mucosal homeostasis through the linking of mucosal defense and regeneration? FEBS Lett (2003) 1.08
Respiratory innate immune proteins differentially modulate the neutrophil respiratory burst response to influenza A virus. Am J Physiol Lung Cell Mol Physiol (2005) 1.08
Active and selective transcytosis of cell-free human immunodeficiency virus through a tight polarized monolayer of human endometrial cells. J Virol (2001) 1.08
Human submandibular saliva aggregates HIV. AIDS Res Hum Retroviruses (1993) 1.05
Phosphate-enhanced transfection of cationic lipid-complexed mRNA and plasmid DNA. Biochim Biophys Acta (1998) 1.03
Human salivary agglutinin binds to lung surfactant protein-D and is identical with scavenger receptor protein gp-340. Biochem J (2001) 1.01
HIV envelope binding by macrophage-expressed gp340 promotes HIV-1 infection. J Immunol (2008) 0.99
Expression of HIV receptors, alternate receptors and co-receptors on tonsillar epithelium: implications for HIV binding and primary oral infection. Virol J (2006) 0.95
Human submandibular saliva specifically inhibits HIV type 1. AIDS Res Hum Retroviruses (1997) 0.95
gp340 (SAG) binds to the V3 sequence of gp120 important for chemokine receptor interaction. AIDS Res Hum Retroviruses (2004) 0.94
Human submandibular saliva inhibits human immunodeficiency virus type 1 infection by displacing envelope glycoprotein gp120 from the virus. J Infect Dis (1998) 0.93
Anti-HIV and -SIV immunity in the vagina. Int Rev Immunol (2003) 0.92
Induction of DMBT1 expression by reduced ERK activity during a gastric mucosa differentiation-like process and its association with human gastric cancer. Carcinogenesis (2005) 0.90
Infection of accessory dendritic cells by human immunodeficiency virus type 1. J Invest Dermatol (1992) 0.90
Immunohistochemical detection of salivary agglutinin/gp-340 in human parotid, submandibular, and labial salivary glands. J Dent Res (2002) 0.89
The N-terminal SRCR-SID domain of gp-340 interacts with HIV type 1 gp120 sequences and inhibits viral infection. AIDS Res Hum Retroviruses (2006) 0.89
Differentiation of columnar epithelia: the hensin pathway. J Cell Sci (2006) 0.86
In vitro infection of epidermal Langerhans cells with human immunodeficiency virus type 1 (HTLV-IIIB isolate). Res Virol (1993) 0.84
HIV in the oral cavity: virus, viral inhibitory activity, and antiviral antibodies: a review. Crit Rev Oral Biol Med (1993) 0.83
Epidermal Langerhans cells and HIV-1 infection. Immunol Lett (1993) 0.79
Salivary agglutinin/DMBT1SAG expression is up-regulated in the presence of salivary gland tumors. J Dent Res (2004) 0.79
The 5' flanking region of the Rhesus monkey H3 (DMBT1) gene contains putative progesterone response elements. DNA Cell Biol (2005) 0.78
Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity (2005) 5.23
mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem (2004) 4.43
Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro. J Leukoc Biol (2002) 2.93
The proteomes of human parotid and submandibular/sublingual gland salivas collected as the ductal secretions. J Proteome Res (2008) 2.53
Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol Ther (2008) 2.50
Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through toll-like receptor 3. J Immunol (2004) 2.42
Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR. J Virol (2003) 2.42
Design of 16S rRNA gene primers for 454 pyrosequencing of the human foregut microbiome. World J Gastroenterol (2010) 2.41
Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference. J Immunol (2002) 2.04
Inhibition of toll-like receptor and cytokine signaling--a unifying theme in ischemic tolerance. J Cereb Blood Flow Metab (2004) 1.65
Increased erythropoiesis in mice injected with submicrogram quantities of pseudouridine-containing mRNA encoding erythropoietin. Mol Ther (2012) 1.61
Systematic comparison of the human saliva and plasma proteomes. Proteomics Clin Appl (2009) 1.51
Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA. Nucleic Acids Res (2011) 1.46
An integrated, self-contained microfluidic cassette for isolation, amplification, and detection of nucleic acids. Biomed Microdevices (2010) 1.42
Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation. Nucleic Acids Res (2010) 1.42
In vivo distribution of a vaginal gel: MRI evaluation of the effects of gel volume, time and simulated intercourse. Contraception (2004) 1.40
Naturally occurring nucleoside modifications suppress the immunostimulatory activity of RNA: implication for therapeutic RNA development. Curr Opin Drug Discov Devel (2007) 1.39
Cutting edge: innate immune system discriminates between RNA containing bacterial versus eukaryotic structural features that prime for high-level IL-12 secretion by dendritic cells. J Immunol (2004) 1.38
Mucosal innate immune factors in the female genital tract are associated with vaginal HIV-1 shedding independent of plasma viral load. AIDS Res Hum Retroviruses (2006) 1.37
Rapid assay format for multiplex detection of humoral immune responses to infectious disease pathogens (HIV, HCV, and TB). Ann N Y Acad Sci (2007) 1.26
gp340 expressed on human genital epithelia binds HIV-1 envelope protein and facilitates viral transmission. J Immunol (2007) 1.25
An isothermal amplification reactor with an integrated isolation membrane for point-of-care detection of infectious diseases. Analyst (2011) 1.25
Salivary diagnostics: the future is now. J Am Dent Assoc (2006) 1.22
Length effects in antimicrobial peptides of the (RW)n series. Antimicrob Agents Chemother (2006) 1.16
A timer-actuated immunoassay cassette for detecting molecular markers in oral fluids. Lab Chip (2008) 1.16
Acute biological effects of simulating the whole-body radiation dose distribution from a solar particle event using a porcine model. Radiat Res (2011) 1.14
Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis. Clin Infect Dis (2013) 1.14
Reduced cell surface expression of CCR5 in CCR5Delta 32 heterozygotes is mediated by gene dosage, rather than by receptor sequestration. J Biol Chem (2001) 1.13
Finger-actuated, self-contained immunoassay cassettes. Biomed Microdevices (2009) 1.09
Thermosiphon-based PCR reactor: experiment and modeling. Anal Chem (2004) 1.07
Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase L. Nucleic Acids Res (2011) 1.07
Comparative in vitro sensitivities of human immune cell lines, vaginal and cervical epithelial cell lines, and primary cells to candidate microbicides nonoxynol 9, C31G, and sodium dodecyl sulfate. Antimicrob Agents Chemother (2002) 1.07
Genetic mapping in mice identifies DMBT1 as a candidate modifier of mammary tumors and breast cancer risk. Am J Pathol (2007) 1.05
Comparative safety evaluation of the candidate vaginal microbicide C31G. Antimicrob Agents Chemother (2005) 1.03
Salivary agglutinin inhibits HIV type 1 infectivity through interaction with viral glycoprotein 120. AIDS Res Hum Retroviruses (2003) 1.01
Neighbor effect on PPII conformation in alanine peptides. J Am Chem Soc (2005) 1.01
Early immunologic failure is associated with early mortality among advanced HIV-infected adults initiating antiretroviral therapy with active tuberculosis. J Infect Dis (2013) 1.00
Effect of solar particle event radiation and hindlimb suspension on gastrointestinal tract bacterial translocation and immune activation. PLoS One (2012) 1.00
Human microbiome and HIV/AIDS. Curr HIV/AIDS Rep (2012) 0.99
HIV envelope binding by macrophage-expressed gp340 promotes HIV-1 infection. J Immunol (2008) 0.99
Upregulation of the phthiocerol dimycocerosate biosynthetic pathway by rifampin-resistant, rpoB mutant Mycobacterium tuberculosis. J Bacteriol (2012) 0.98
Multivalent antimicrobial peptides from a reactive polymer scaffold. J Med Chem (2006) 0.98
Structural and functional modeling of human lysozyme reveals a unique nonapeptide, HL9, with anti-HIV activity. Biochemistry (2005) 0.97
Exogenous siRNA mediates sequence-independent gene suppression by signaling through toll-like receptor 3. Cells Tissues Organs (2004) 0.97
Control of bacterial persister cells by Trp/Arg-containing antimicrobial peptides. Appl Environ Microbiol (2011) 0.96
A microfluidic system for saliva-based detection of infectious diseases. Ann N Y Acad Sci (2007) 0.96
MiR-221/222 promote human glioma cell invasion and angiogenesis by targeting TIMP2. Tumour Biol (2015) 0.95
gp340 (SAG) binds to the V3 sequence of gp120 important for chemokine receptor interaction. AIDS Res Hum Retroviruses (2004) 0.94
The mouth: a gateway or a trap for HIV? AIDS (2010) 0.93
Antimicrobial dendrimer active against Escherichia coli biofilms. Bioorg Med Chem Lett (2009) 0.92
Tuning the membrane selectivity of antimicrobial peptides by using multivalent design. Chembiochem (2007) 0.91
Feasibility of implementing rapid oral fluid HIV testing in an urban University Dental Clinic: a qualitative study. BMC Oral Health (2012) 0.91
Distribution of a 3.5-mL (1.0%) C31G vaginal gel using magnetic resonance imaging. Contraception (2005) 0.91
Short interfering RNA-mediated inhibition of herpes simplex virus type 1 gene expression and function during infection of human keratinocytes. J Virol (2004) 0.90
Vaccine-delivered HIV envelope inhibits CD4(+) T-cell activation, a mechanism for poor HIV vaccine responses. Blood (2006) 0.90
In vitro transcription of long RNA containing modified nucleosides. Methods Mol Biol (2013) 0.90
The N-terminal SRCR-SID domain of gp-340 interacts with HIV type 1 gp120 sequences and inhibits viral infection. AIDS Res Hum Retroviruses (2006) 0.89
Synthetic cervical mucus formulation. Contraception (2002) 0.88
Development of a generic microfluidic device for simultaneous detection of antibodies and nucleic acids in oral fluids. Biomed Res Int (2013) 0.88
A Qualitative Study of Patients' Attitudes toward HIV Testing in the Dental Setting. Nurs Res Pract (2012) 0.88
Effect of solar particle event radiation on gastrointestinal tract bacterial translocation and immune activation. Radiat Res (2011) 0.88
Patient and provider acceptance of oral HIV screening in a dental school setting. J Dent Educ (2012) 0.88
Effect of GB virus C viremia on HIV acquisition and HIV set-point. AIDS (2005) 0.87
Using Transcranial Direct Current Stimulation to Treat Depression in HIV-Infected Persons: The Outcomes of a Feasibility Study. Front Psychiatry (2012) 0.86
Contribution of hydrogen bonding to protein stability estimated from isotope effects. Biochemistry (2002) 0.86
Spin relaxation enhancement confirms dominance of extended conformations in short alanine peptides. Angew Chem Int Ed Engl (2007) 0.85
Vaccinating HIV patients: focus on human papillomavirus and herpes zoster vaccines. AIDS Rev (2013) 0.85
Improved assay to detect Plasmodium falciparum using an uninterrupted, semi-nested PCR and quantitative lateral flow analysis. Malar J (2013) 0.84
Quantitative analysis of differentially expressed saliva proteins in human immunodeficiency virus type 1 (HIV-1) infected individuals. Anal Chim Acta (2013) 0.83
RNA based vaccines. DNA Cell Biol (2002) 0.83
HIV envelope suppresses CD4+ T cell activation independent of T regulatory cells. J Immunol (2008) 0.82
Effect of protease inhibitors on the quantitative and qualitative assessment of oral microorganisms. FEMS Microbiol Lett (2010) 0.81
Development of a microfluidic device for detection of pathogens in oral samples using upconverting phosphor technology (UPT). Ann N Y Acad Sci (2007) 0.81
Detecting viruses by using salivary diagnostics. J Am Dent Assoc (2012) 0.81
Lesson learned and dispelled myths: three-dimensional imaging of the human vagina. Fertil Steril (2004) 0.80
Synthetic dendrimeric peptide active against biofilm and persister cells of Pseudomonas aeruginosa. Appl Microbiol Biotechnol (2015) 0.80
Extracellular mRNA induces dendritic cell activation by stimulating tumor necrosis factor-alpha secretion and signaling through a nucleotide receptor. J Biol Chem (2002) 0.80
Comparison of oral fluid collectors for use in a rapid point-of-care diagnostic device. Clin Diagn Lab Immunol (2004) 0.79
HIV infection and microbial diversity in saliva. J Clin Microbiol (2014) 0.79
In vitro test to evaluate the interaction between synthetic cervical mucus and vaginal formulations. AAPS PharmSciTech (2004) 0.78
Transfection of pseudouridine-modified mRNA encoding CPD-photolyase leads to repair of DNA damage in human keratinocytes: a new approach with future therapeutic potential. J Photochem Photobiol B (2013) 0.78
Saliva and viral infections. Periodontol 2000 (2016) 0.78
Induction of HIV-specific T and B cell responses with a replicating and conditionally infectious lentiviral vaccine. Eur J Immunol (2008) 0.77
SIV antigen immunization induces transient antigen-specific T cell responses and selectively activates viral replication in draining lymph nodes in retroviral suppressed rhesus macaques. Retrovirology (2011) 0.76
Developing patient-centered treatment protocols in brain stimulation: a rationale for combining quantitative and qualitative approaches in persons with HIV. J Am Psychiatr Nurses Assoc (2012) 0.75
An electrochemiluminescence assay for gp340 (DMBT1). Anal Biochem (2013) 0.75